Beckman Coulter will give a keynote industry presentation on the diagnosis of haematolymphoid malignancies at this year’s European Society for Clinical Cell Analysis (ESCCA) meeting, which takes place in the Porto Palace Conference Centre & Hotel, Thessaloniki, Greece, on 24– 27 September 2017. The role of flow cytometry in 24/7 immune monitoring of trauma patients, analysis of rare abnormal leucocytes and assessment of immune deficiencies will be demonstrated and discussed in a range of educational programmes organised by the company.
Beckman Coulter is one of the premier sponsors of the 2017 ESCCA event. ESCCA was founded to carry forward the work of the European Working Group on Clinical Cell Analysis (EWGCCA), a joint initiative by 16 European centres to foster and develop flow cytometric applications for clinical purposes.